M-SRG

品系全名

SD-Rag2em1SmocIl2rgem1Smoc

目錄號(hào)

NR-KO-210360

品系狀態(tài)

活體

導(dǎo)出PDF

基因信息

基因名

品系描述

利用CRISPR基因編輯技術(shù),敲除Rag2-KO(SD)大鼠IL2rg基因的exon 2-7,建立Rag2和Il2rg基因敲除大鼠模型。

驗(yàn)證數(shù)據(jù)

image.png

Fig1. Complete deletion of T, B and NK cells of M-SRG rats. Spleen and peripheral blood cells from SD and M-SRG rats were collected to analyze their compositions of T, B and NK cells by FACS.

image.png

Fig2. Subcutaneous xenograft tumor growth of HT29 cells in M-SRG rats.? Human colorectal adenocarcinoma cell line HT-29 (2x107) were mixed with Matrigel and inoculated subcutaneously into M-SRG rats (n=6). (A)Tumor volume. (B) Body weight change.

image.pngFig3. Subcutaneous xenograft tumor growth of PC-3 cells in M-SRG rats. Human prostatic adenocarcinoma cell line PC-3 (2x107) were mixed with Matrigel and inoculated subcutaneously into M-SRG rats (n=6). (A)Tumor volume. (B) Body weight change.

image.png

Fig4. Subcutaneous xenograft tumor growth of LNCaP clone FGC cells in M-SRG rats. Human metastatic prostate carcinoma cell line LNCaP clone FGC (2x107) were mixed with Matrigel and inoculated subcutaneously into M-SRG rats (n=6). (A)Tumor volume. (B) Body weight change.?

image.png

Fig5. Subcutaneous xenograft tumor growth of A2780 cells in M-SRG rats.? Human ovarian cancer cell line HT-29 (1x107) were mixed with Matrigel and inoculated subcutaneously into M-SRG rats (n=6). (A)Tumor volume. (B) Body weight change.?

image.png

Fig6. Subcutaneous xenograft tumor growth of MV4-11 cells in M-SRG?rats. Human monocytic leukemia cell line MV4-11 (1x107) were mixed with Matrigel and inoculated subcutaneously into M-SRG?rats (n=6). (A)Tumor volume. (B) Body weight change.?

image.png

Fig7. Subcutaneous xenograft tumor growth of OCI-AML-3 cells in M-SRG rats.? Human acute myeloid leukemia cell line OCI-AML-3 (1x107) were mixed with Matrigel and inoculated subcutaneously into M-SRG rats (n=6). (A) Tumor volume. (B) Body weight change.image.png

Fig8. Blood Routine Tests in M-SRG rats.??

image.png

Fig9. Blood biochemistry in M-SRG rats.?


你也可能感興趣

Tamoxifen誘導(dǎo)Cre-ERT2小鼠 使用指南

Cre-ERT2在無(wú)Tamoxifen誘導(dǎo)的情況下,在細(xì)胞質(zhì)內(nèi)處于無(wú)活性狀態(tài);當(dāng)Tamoxifen誘導(dǎo)后,Tamoxifen的代謝產(chǎn)物4-OHT(雌激素類似物)與ERT結(jié)合,可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。

查看
【小鼠大學(xué)問(wèn)】基因工程小鼠的命名規(guī)則

常見(jiàn)的基因工程小鼠可以分為兩種命名方式,包括基因定點(diǎn)修飾的小鼠命名,比如:敲除、敲入、點(diǎn)突變等等,和隨機(jī)轉(zhuǎn)基因的小鼠命名。

查看